<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000405883">
  <TermName>NSC 655649</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called antitumor antibiotics and topoisomerase inhibitors. Also called rebeccamycin analog.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>NSC 655649</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de antibiótico antitumoral y de inhibidor de la topoisomerasa. También se llama análogo de la rebecamicina.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2004-11-22</DateFirstPublished>
  <DateLastModified>2006-11-07</DateLastModified>
</GlossaryTerm>
